Back to Clearbridge Investments, LLC Clearbridge Investments, LLC

AGNAGN
7 quarters

Position history for Clearbridge Investments, LLCClearbridge Investments, LLC's holdings in ALLERGAN PLC

As of its Q1 2020 13F, Clearbridge Investments held 4,085,721 shares of AGN (Allergan), worth $723.6M. Clearbridge Investments' 13F filings listed AGN from Q4 2018 to Q1 2020, 6 quarterly filings. AGN was 0.8% of Clearbridge Investments' reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$1.1B

Total Shares Change

-8.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2020-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2020-Q1
Decreased
4.1M
-21.1%
$723.6M0.8%—
0
2019-Q4
Decreased
5.2M
-26.5%
$995.1M0.8%—
0
2019-Q3
Decreased
7M
-14.8%
$1.2B1.0%—
0
2019-Q2
Decreased
8.3M
-9.8%
$1.4B1.2%—
0
2019-Q1
Increased
9.2M
+8.6%
$1.3B1.2%—
55
2018-Q4
First report
8.4M
-
$1.1B1.1%—
0

Other major holders of AGN: STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used